Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a Phase I/II clinical study conducted in participants with relapsed/refractory B-Cell Non-Hodgkin Lymphoma. The study aims to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SYS6055 Injection in participants with relapsed/refractory aggressive B-cell lymphoma, and to provide a basis for the recommended dosing regimen in subsequent studies.
Epistemonikos ID: 57fd9064483d3f7f6622e5e8cf312484401ab614
First added on: Oct 30, 2026